631 related articles for article (PubMed ID: 35844124)
21. Factors associated with positive predictive value of preliminary screening in a two-step screening strategy for colorectal neoplasms in China.
Li JB; Qiu ZY; Deng YX; Li Y; Lin ZC; Wu YP; Weng F; Tian H; Ou QJ; Gong CH; Pan ZZ; Wan DS; Peng JH; Fang YJ
Discov Oncol; 2022 Jan; 13(1):4. PubMed ID: 35201502
[TBL] [Abstract][Full Text] [Related]
22. Methylation of Septin9, SRSF1, and PAX8 in Early Screening of Colorectal Cancer in the Population Undergoing Physical Examinations.
Li Q; Jiang W; Zhang Y; Yang X; Huang T; Huang Y; Yang S; Wang Q
Clin Lab; 2023 Dec; 69(12):. PubMed ID: 38084698
[TBL] [Abstract][Full Text] [Related]
23. Effects of Increasing Screening Age and Fecal Hemoglobin Cutoff Concentrations in a Colorectal Cancer Screening Program.
Wieten E; Schreuders EH; Nieuwenburg SA; Hansen BE; Lansdorp-Vogelaar I; Kuipers EJ; Bruno MJ; Spaander MC
Clin Gastroenterol Hepatol; 2016 Dec; 14(12):1771-1777. PubMed ID: 27567693
[TBL] [Abstract][Full Text] [Related]
24. A combination of clinical risk stratification and fecal immunochemical test is useful for identifying persons with high priority of early colonoscopy.
Jung YS; Park CH; Kim NH; Park JH; Park DI; Sohn CI
Dig Liver Dis; 2018 Mar; 50(3):254-259. PubMed ID: 29198569
[TBL] [Abstract][Full Text] [Related]
25. [Distribution characteristics and risk factors of colorectal adenomas].
Zhou H; Shen Z; Zhao J; Zhou Z; Xu Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Jun; 21(6):678-684. PubMed ID: 29968244
[TBL] [Abstract][Full Text] [Related]
26. Validation of the Asia Pacific Colorectal Screening (APCS) score in a Western population: An alternative screening tool.
Corte C; Zhang L; Chen J; Westbury S; Shaw J; Yeoh KG; Leong R
J Gastroenterol Hepatol; 2016 Feb; 31(2):370-5. PubMed ID: 26485170
[TBL] [Abstract][Full Text] [Related]
27. Performance of two faecal immunochemical tests for the detection of advanced neoplasia at different positivity thresholds: a cross-sectional study of the Dutch national colorectal cancer screening programme.
de Klerk CM; Wieten E; Lansdorp-Vogelaar I; Bossuyt PM; Spaander MC; Dekker E
Lancet Gastroenterol Hepatol; 2019 Feb; 4(2):111-118. PubMed ID: 30497962
[TBL] [Abstract][Full Text] [Related]
28. A Comparison of Single and Combined Schemes of Asia-Pacific Colorectal Screening, Faecal Immunochemical and Stool Deoxyribonucleic Acid Testing for Community Colorectal Cancer Screening.
Ze Y; Tu H; Zhang L; Bai Y; Ren Y; Chen X; Xue Y; Sun R; Yang Y; Yang J; Zhou X; Liu L
J Multidiscip Healthc; 2023; 16():571-586. PubMed ID: 36883167
[TBL] [Abstract][Full Text] [Related]
29. Adenoma Detection Rate in Asymptomatic Patients with Positive Fecal Immunochemical Tests.
Kligman E; Li W; Eckert GJ; Kahi C
Dig Dis Sci; 2018 May; 63(5):1167-1172. PubMed ID: 29468377
[TBL] [Abstract][Full Text] [Related]
30. Colorectal cancer screening with fecal immunochemical testing: a community-based, cross-sectional study in average-risk individuals in Nigeria.
Alatise OI; Dare AJ; Akinyemi PA; Abdulkareem FB; Olatoke SA; Knapp GC; Kingham TP;
Lancet Glob Health; 2022 Jul; 10(7):e1012-e1022. PubMed ID: 35714629
[TBL] [Abstract][Full Text] [Related]
31. Divergent Long-Term Detection Rates of Proximal and Distal Advanced Neoplasia in Fecal Immunochemical Test Screening Programs: A Retrospective Cohort Study.
Zorzi M; Hassan C; Capodaglio G; Narne E; Turrin A; Baracco M; Dal Cin A; Fiore A; Martin G; Repici A; Rex D; Rugge M
Ann Intern Med; 2018 Nov; 169(9):602-609. PubMed ID: 30285055
[TBL] [Abstract][Full Text] [Related]
32. Age- and sex-stratified detection rates and associated factors of colorectal neoplasia in the Tianjin colorectal cancer screening program from 2012 to 2020.
Yuan Z; Wang S; Wang Y; Li H; Gao W; Liu X; Han Y; Liu Z; Zhang Q; Ma H; Wang J; Wei X; Zhang X; Cui W; Zhang C
BMC Gastroenterol; 2023 Dec; 23(1):435. PubMed ID: 38087194
[TBL] [Abstract][Full Text] [Related]
33. Fecal MicroRNA-Based Algorithm Increases Effectiveness of Fecal Immunochemical Test-Based Screening for Colorectal Cancer.
Duran-Sanchon S; Moreno L; Gómez-Matas J; Augé JM; Serra-Burriel M; Cuatrecasas M; Moreira L; Serradesanferm A; Pozo À; Grau J; Pellisé M; Gironella M; Castells A
Clin Gastroenterol Hepatol; 2021 Feb; 19(2):323-330.e1. PubMed ID: 32113893
[TBL] [Abstract][Full Text] [Related]
34. Adding family history to faecal immunochemical testing increases the detection of advanced neoplasia in a colorectal cancer screening programme.
Kallenberg FG; Vleugels JL; de Wijkerslooth TR; Stegeman I; Stoop EM; van Leerdam ME; Kuipers EJ; Bossuyt PM; Dekker E
Aliment Pharmacol Ther; 2016 Jul; 44(1):88-96. PubMed ID: 27170502
[TBL] [Abstract][Full Text] [Related]
35. Screening by Total Colonoscopy Following Fecal Immunochemical Tests and Determinants of Colorectal Neoplasia in Japanese Men With Alcohol Dependence.
Mizukami T; Yokoyama A; Yokoyama T; Onuki S; Maruyama K
Alcohol Alcohol; 2017 Mar; 52(2):131-137. PubMed ID: 28182201
[TBL] [Abstract][Full Text] [Related]
36. The Asia-Pacific Colorectal Screening score: a validated tool that stratifies risk for colorectal advanced neoplasia in asymptomatic Asian subjects.
Yeoh KG; Ho KY; Chiu HM; Zhu F; Ching JY; Wu DC; Matsuda T; Byeon JS; Lee SK; Goh KL; Sollano J; Rerknimitr R; Leong R; Tsoi K; Lin JT; Sung JJ;
Gut; 2011 Sep; 60(9):1236-41. PubMed ID: 21402615
[TBL] [Abstract][Full Text] [Related]
37. Predictive Modeling of Colonoscopic Findings in a Fecal Immunochemical Test-Based Colorectal Cancer Screening Program.
Law J; Rajan A; Trieu H; Azizian J; Berry R; Beaven SW; Tabibian JH
Dig Dis Sci; 2022 Jul; 67(7):2842-2848. PubMed ID: 34350518
[TBL] [Abstract][Full Text] [Related]
38. Correlation of Fecal Immunochemical Testing Levels With Pathology Results in a National Colorectal Cancer Screening Program.
O'Reilly SM; MacNally S; O'Donoghue D; Mooney T; Fitzpatrick P; Mulcahy HE; Cullen G
Clin Transl Gastroenterol; 2021 Jan; 12(1):e00277. PubMed ID: 33512944
[TBL] [Abstract][Full Text] [Related]
39. Fecal Immunologic Test Results and Diagnostic Colonoscopy in a Mexican Population at Average Risk for Colorectal Cancer.
Manzano-Robleda MDC; Espinosa-Tamez P; Potter MB; Lajous M; Van Loon K; Zhang L; Jimenez-Peña A; Sánchez Del Monte J; Mohar A; Hernández-Guerrero A
Cancer Prev Res (Phila); 2020 Nov; 13(11):959-966. PubMed ID: 32655008
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic Yield of One-Time Colonoscopy vs One-Time Flexible Sigmoidoscopy vs Multiple Rounds of Mailed Fecal Immunohistochemical Tests in Colorectal Cancer Screening.
Grobbee EJ; van der Vlugt M; van Vuuren AJ; Stroobants AK; Mallant-Hent RC; Lansdorp-Vogelaar I; Bossuyt PMM; Kuipers EJ; Dekker E; Spaander MCW
Clin Gastroenterol Hepatol; 2020 Mar; 18(3):667-675.e1. PubMed ID: 31419575
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
